The Male Reproductive System

The male reproductive system is built around a division of labor that is easy to state but easy to misremember: Leydig cells make testosterone; Sertoli cells make sperm possible. Leydig cells sit in the interstitial spaces between seminiferous tubules and respond to luteinizing hormone (LH) by converting cholesterol into testosterone. Sertoli cells line the seminiferous tubules themselves, respond to follicle-stimulating hormone (FSH) and to local testosterone, and physically and biochemically support developing germ cells from the basal lamina to the tubule lumen. No germ cell touches the tubule's basement membrane or lumen fluid without Sertoli cell mediation. Spermatogenesis is the process by which diploid stem cells (spermatogonia, 2n) become haploid, motile spermatozoa (n). It has three conceptually distinct phases: a mitotic phase that maintains the stem cell pool and produces committed progenitors, a meiotic phase that halves chromosome number and shuffles alleles by Crossing Over, and a morphological remodeling phase called spermiogenesis that converts a round haploid cell into a streamlined, flagellated sperm. This entire assembly line is powered and permitted by androgens, principally testosterone and its potent derivative dihydrotestosterone (DHT), acting locally within the testis and systemically throughout the body. Everything is governed by the hypothalamic-pituitary-gonadal axis, the male-specific version of a hormonal cascade pattern seen across Endocrine Signaling systems generally: a hypothalamic releasing hormone drives anterior pituitary tropic hormones, which drive a peripheral gland, whose products feed back to suppress the hypothalamus and pituitary. In the male, gonadotropin-releasing hormone (GnRH) is released in pulses, LH and FSH are the tropic hormones, and testosterone and inhibin are the feedback signals. Because the loop is negative, the system self-stabilizes around a set point, much as a thermostat holds a room temperature — except here the "temperature" is androgen tone and sperm output, held roughly constant across decades of adult life.

1. Gross and microscopic anatomy of the testis. Each testis is enclosed in a tough fibrous capsule (tunica albuginea) that sends septa inward, dividing the organ into roughly 250–300 lobules. Each lobule contains one to several highly coiled seminiferous tubules — about 250 meters of tubule per testis if uncoiled — where sperm are made. Between the tubules lies loose interstitial connective tissue containing Leydig cells, blood vessels, and lymphatics. Sperm produced in the tubules travel through a short straight segment (tubulus rectus), a network (rete testis), then out through 10–15 efferent ductules into a single, tightly coiled epididymis (about 4–6 meters uncoiled), where they gain motility and fertilizing capacity over roughly 2–12 days of maturation and are stored until ejaculation.

2. The seminiferous epithelium. Cross-sectioning a tubule reveals a stratified epithelium resting on a basal lamina. Spermatogonia sit at the base; progressively more mature germ cells (spermatocytes, then spermatids) lie progressively closer to the lumen, with mature spermatozoa released into the lumen itself. Interspersed among the germ cells, spanning the full height of the epithelium, are Sertoli cells — tall columnar cells joined to each other near the basal lamina by tight junctions. These tight junctions constitute the blood-testis barrier, dividing the epithelium into a basal compartment (spermatogonia, early spermatocytes) and an adluminal compartment (later spermatocytes, spermatids, sperm) that is immunologically and chemically sequestered from the general circulation.

3. Why the barrier exists. Haploid and recombined germ cells display surface antigens not present during fetal immune "self" education, so if they were exposed to the systemic immune system, they could trigger an autoimmune attack. The blood-testis barrier prevents this, and it also lets Sertoli cells build a customized luminal fluid — with its own ionic composition, androgen concentration (bound to androgen-binding protein, ABP), and metabolic substrates (Sertoli cells convert glucose to lactate, the preferred germ cell fuel) — that meiotic and post-meiotic cells absolutely require.

4. Mitotic phase. Spermatogonia are diploid stem cells in the basal compartment. Type A spermatogonia divide by mitosis; some divisions are self-renewing (maintaining the stem pool indefinitely) and some produce Type B spermatogonia committed to differentiation. Type B spermatogonia divide mitotically once more to form primary spermatocytes, which then cross the blood-testis barrier (via transient, migrating tight-junction remodeling) into the adluminal compartment.

5. Meiotic phase. Primary spermatocytes (4n DNA content, still technically diploid in chromosome number until anaphase I) enter meiosis I, an unusually long phase in humans — prophase I alone lasts roughly three weeks — during which homologous chromosomes pair and exchange DNA by crossing over, generating genetic diversity. Meiosis I yields two secondary spermatocytes (haploid, 2n DNA/1n chromosomes), which rapidly complete meiosis II to yield four haploid spermatids (1n DNA/1n chromosomes) per original primary spermatocyte.

6. Spermiogenesis. Spermatids are round, ordinary-looking haploid cells that must be remodeled into functional gametes without any further division. The Golgi apparatus builds an acrosomal cap containing hydrolytic enzymes (used later to penetrate the oocyte's coats); centrioles organize a flagellar axoneme; mitochondria wrap in a helical sheath around the flagellum's midpiece to power motility; nuclear chromatin condenses and histones are largely replaced by protamines, compacting the DNA into a dense, transcriptionally silent package; and most cytoplasm is shed as a residual body, phagocytosed by the Sertoli cell. The result is a spermatozoon: head (nucleus + acrosome), midpiece (mitochondria), and tail (flagellum).

7. Spermiation and transit. Mature spermatozoa are released from the Sertoli cell into the tubule lumen (spermiation) and are non-motile at this point; motility and full fertilizing competence develop later during epididymal transit and, finally, capacitation in the female tract — a maturation step covered in the physiology of Fertilization.

8. Timing. In humans, one complete cycle of the seminiferous epithelium (the time for a given point in the tubule to cycle through all stages) is about 16 days; a spermatogonium takes about 4.5 cycles, roughly 64–74 days, to become a released spermatozoon. Because different segments of a tubule are offset in their cycle, sperm are produced continuously rather than in synchronized batches — unlike the strictly cyclical, single-oocyte-per-cycle pattern in the ovary.

9. Leydig cells and testosterone synthesis. LH binds Leydig cell membrane receptors (G-protein-coupled, cAMP-mediated), stimulating cholesterol uptake and its conversion via the enzyme cascade (cholesterol → pregnenolone → progesterone-pathway intermediates → androstenedione → testosterone) using steroidogenic enzymes including CYP11A1, 3β-HSD, CYP17A1, and 17β-HSD. Because testosterone is a steroid, it diffuses freely across membranes rather than being stored in vesicles; secretion rate tracks synthesis rate directly. Testosterone acts locally at high concentration on adjacent Sertoli cells (essential for spermatogenesis) and systemically at lower concentration on distant tissues (genitalia, muscle, bone, brain, larynx). In some peripheral tissues it is converted by 5α-reductase to dihydrotestosterone (DHT), a more potent androgen receptor agonist responsible for prostate growth and external genital masculinization, or aromatized to estradiol, which contributes to epiphyseal closure and bone maturation even in males.

10. FSH and Sertoli cell function. FSH binds Sertoli cell receptors and, via cAMP, stimulates production of androgen-binding protein (concentrates testosterone in the tubule lumen), inhibin (feedback signal), transferrin and other nutritive factors for germ cells, and factors supporting blood-testis barrier integrity and spermiogenesis. Sertoli cells thus translate two upstream signals — FSH from the pituitary and testosterone diffusing over from neighboring Leydig cells — into the local environment that spermatogenesis depends on.

11. The negative feedback loop. The hypothalamus releases GnRH in discrete pulses (roughly every 1–3 hours) into the hypophyseal portal circulation. Pulsatile GnRH stimulates the anterior pituitary gonadotrophs to secrete LH and FSH. Testosterone feeds back to suppress GnRH pulse frequency at the hypothalamus and LH sensitivity at the pituitary — a classic long-loop negative feedback. Inhibin, secreted by Sertoli cells in response to FSH (and to rising sperm counts, functioning almost as a "sperm count sensor"), selectively suppresses FSH secretion at the pituitary with little effect on LH — a second, independent negative feedback loop layered on top of the first.

12. Ejaculatory pathway (brief). Sperm stored in the epididymis and vas deferens are propelled at ejaculation by smooth-muscle peristalsis; they are mixed with secretions from the seminal vesicles (fructose-rich, alkaline, roughly 60% of semen volume), the prostate (proteolytic enzymes, citrate, zinc, roughly 30%), and the bulbourethral glands (lubricating mucus), forming semen. This accessory-gland output is itself testosterone-dependent, another downstream consequence of the same hormonal axis.

Hypophysectomy and hormone-replacement experiments (established the LH/FSH division of labor, mid-20th century). Researchers surgically removed the pituitary (hypophysectomy) from adult male rats, producing immediate testicular atrophy: seminiferous tubules shrank, spermatogenesis halted at early stages, and Leydig cells regressed. This showed the testis is not autonomous but pituitary-dependent. Crucially, when investigators then replaced only LH, Leydig cells and testosterone output recovered, but spermatogenesis remained arrested at spermatocyte stages — sperm production did not resume. When they replaced both LH and FSH, full spermatogenesis resumed. This dissociation experiment — LH alone rescues steroidogenesis, LH+FSH together rescue gametogenesis — is the direct evidence for assigning testosterone production to Leydig cells (LH target) and full spermatogenic support to Sertoli cells (FSH target, requiring intratesticular testosterone as well). Later work refined this further: FSH is not absolutely required to initiate spermatogenesis at puberty in every species, but it strongly promotes efficiency, germ cell survival, and Sertoli cell proliferation during the prepubertal window, while high intratubular testosterone concentration (roughly 100 times higher than blood levels, achieved because Sertoli-cell ABP concentrates it locally) is indispensable for completing meiosis and spermiogenesis.

Radioisotope labeling and the discovery of spermatogenic timing (Clermont, 1960s–70s). Yves Clermont injected tritiated thymidine (³H-thymidine), which is incorporated into DNA only during S-phase, into rats and later into human volunteers undergoing testicular biopsy for other clinical reasons. By tracking the labeled cohort of cells over successive biopsies taken days to weeks apart, he could follow a single generation of germ cells as it progressed through defined morphological stages of the seminiferous epithelium. This let him measure, directly and quantitatively, that the human seminiferous cycle takes about 16 days and that full spermatogenesis takes about 74 days (values later refined to roughly 64–74 days with additional epididymal transit) — numbers that could not have been obtained from static histology alone, since a single cross-section only shows a snapshot, not a rate. This is the classic pulse-chase logic (the same logic later reused in a related form by Meselson and Stahl to track DNA replication) applied to a differentiating cell population rather than a molecule.

Discovery of the blood-testis barrier (Dym and Fawcett, 1970). Using electron microscopy and, critically, a lanthanum tracer injected into the vasculature, Martin Dym and Don Fawcett showed that lanthanum (an electron-dense marker visible by EM) permeated the tubule as far as the base of the Sertoli cell layer but stopped abruptly at a specific level marked by Sertoli-Sertoli tight junctions, never reaching the adluminal compartment where meiotic and post-meiotic germ cells reside. This directly visualized and localized the blood-testis barrier, proving it is formed by Sertoli cell junctional complexes rather than by the tubule's blood vessels themselves, and explaining why immune cells and macromolecules in blood cannot reach late-stage germ cells.

Isolation and characterization of inhibin (1980s). For decades physiologists inferred, from the observation that FSH rose sharply after damage to seminiferous tubules (for example after cryptorchidism or irradiation) even while LH and testosterone stayed normal, that some testis-derived factor selectively suppressed FSH. This was formalized as "inhibin," but its chemical identity was unknown for nearly 50 years after the term was coined in 1932. In the 1980s, several groups (including McLachlan, de Kretser, and colleagues, plus parallel work isolating the related activin) purified inhibin from testicular and follicular fluid and characterized it as a glycoprotein dimer of α and β subunits, and showed by injection that purified inhibin selectively suppresses FSH secretion without altering LH — confirming the two-feedback-loop model (testosterone → suppresses LH primarily; inhibin → suppresses FSH primarily) directly rather than by inference.

Example 1 — Reading a hormone panel to localize a lesion in the HPG axis. A 24-year-old man presents with infertility and low libido. Labs show:

Reasoning: testosterone is low, and both LH and FSH are also low (not elevated). If the defect were primary testicular failure (e.g., destroyed Leydig and Sertoli cells), the axis would lose its negative feedback, and the pituitary would respond by driving LH and FSH up in a compensatory attempt — exactly as seen in primary hypogonadism. Here, instead, LH and FSH are low alongside low testosterone, meaning the pituitary or hypothalamus itself is underdriving the testis: this is secondary (hypogonadotropic) hypogonadism. A follow-up GnRH stimulation test showing a normal LH/FSH rise would localize the defect to the hypothalamus (insufficient GnRH pulses, e.g., Kallmann syndrome); a blunted response would point to a pituitary lesion. This is the same logic clinicians use throughout endocrinology: compare the tropic hormone level to the gland-hormone level to decide whether feedback is intact, absent, or overridden.

Example 2 — Estimating daily sperm output from cycle kinetics. Suppose a testicular biopsy shows that each cross-section of tubule contains, on average, 4 identifiable generations of germ cells undergoing active division/differentiation simultaneously (a real feature of the "wave" of spermatogenesis, since the epithelium is not perfectly synchronized), and that one human testis contains approximately 250 meters of seminiferous tubule with roughly 3 × 10⁸ actively spermatogenic stem-cell-lineage columns along its length (a simplified didactic figure, not a precise histological count). If the full 64-day spermatogenic process yields, from a single committed Type B spermatogonium (after 2 mitotic divisions → 4 cells, then meiosis I and II → 4× haploid spermatids each), a net amplification factor of 4 × 4 = 16 spermatids per original Type B spermatogonium (ignoring some physiological attrition/apoptosis, which in reality removes a substantial fraction — commonly cited losses reduce net yield well below the theoretical maximum), then:

• Theoretical yield per spermatogonial input cohort = input × 16
• Observed physiological output ≈ 200 million sperm/day per adult male (a directly measured clinical/andrology figure, from ejaculate counts and turnover studies)
• Over a 64–74 day cycle, roughly 1.3–1.5 × 10¹⁰ sperm are "in production" in the tubules at any moment, since output continues throughout the cycle rather than emerging as one synchronized batch.

The teaching point: the discrepancy between the theoretical 16-fold amplification and observed output is explained by real, measured germ cell apoptosis (often over 50% of potential spermatids are lost during meiosis and spermiogenesis, a quality-control mechanism analogous to negative selection elsewhere in biology), so the "assembly line" is deliberately lossy, not just efficient.

Knobil's most famous demonstration used monkeys whose own hypothalamic GnRH neurons had been destroyed by a lesion, rendering them unable to secrete LH or FSH at all. He then infused synthetic GnRH either continuously (as a constant intravenous drip) or in hourly pulses via a programmable pump. Continuous GnRH infusion failed to restore LH/FSH secretion — indeed it suppressed the pituitary's GnRH receptors through downregulation, a phenomenon now central to the mechanism of GnRH-agonist drugs used to suppress reproductive hormones therapeutically (for example in prostate cancer treatment). Only pulsatile infusion, matching the natural roughly hourly rhythm, restored normal cyclic LH and FSH secretion. This work reframed the entire hypothalamic-pituitary-gonadal axis as fundamentally a pulse-frequency-encoded signaling system, not a simple concentration-dependent one — a principle that also underlies Sherwood-style textbook explanations of the axis in both sexes and directly informs why continuous GnRH-agonist therapy is used clinically to shut down the gonadal axis (paradoxically, by overstimulating and desensitizing it), while pulsatile GnRH is used to restore fertility in men with hypothalamic hypogonadism.

Male hormonal contraception. Because exogenous testosterone (alone or with a progestin) suppresses LH and FSH and thereby suppresses spermatogenesis, this exact feedback mechanism is the basis of experimental male hormonal contraceptives, several of which have reached large multi-country clinical trials with reversible near-azoospermia as the endpoint.

Testosterone replacement therapy (TRT). Men with confirmed hypogonadism (low testosterone plus low or inappropriately normal LH/FSH, or primary testicular failure) are treated with exogenous testosterone; clinicians must specifically counsel that TRT commonly suppresses fertility via the same negative-feedback mechanism, which is why men wishing to preserve fertility are often given alternatives such as clomiphene (which blocks estrogen negative feedback at the hypothalamus, raising endogenous LH/FSH) or hCG (an LH mimic) instead.

Infertility workup. The LH/FSH/testosterone panel described in Worked Example 1 is standard clinical practice for distinguishing primary (testicular) from secondary (hypothalamic/pituitary) causes of male infertility, directly guiding whether treatment should target the gonad, the pituitary, or the hypothalamus.

Cryptorchidism and testicular cancer risk. Because normal spermatogenesis requires the testis to be at scrotal temperature (2–4°C below core body temperature — the physiological reason for the scrotum's location outside the body cavity), undescended testes (cryptorchidism) impair spermatogenesis and substantially raise testicular cancer risk, motivating early surgical correction (orchiopexy) in pediatric practice.

Prostate cancer therapy. GnRH agonists, exploiting the very desensitization phenomenon Knobil characterized, are used to chemically suppress testosterone production ("medical castration") in androgen-sensitive prostate cancer, since tumor growth is often testosterone-dependent.

Anabolic steroid harm reduction and sports medicine. Understanding that exogenous androgens suppress the HPG axis underlies clinical counseling and recovery protocols (including post-cycle therapy) for athletes and bodybuilders using anabolic-androgenic steroids, and explains the testicular atrophy and infertility associated with their misuse.

Assisted reproduction. In cases of very low sperm counts, techniques such as testicular sperm extraction (TESE) combined with intracytoplasmic sperm injection (ICSI) rely directly on understanding where in the seminiferous tubule viable, late-stage haploid sperm can be biopsied and retrieved even when ejaculate counts are near zero.

Ask the tutor: How does the same HPG-axis logic get rewired into the cyclical, rather than continuous, hormone pattern seen in the female reproductive system?